Success Stories

Event Videos

Neonatal Jaundice NEONATAL JAUNDICE (JAUNDICE IN NEWBORN) What is jaundice? Increase in Bilirubin (yellow pigment) in blood beyond the normal range is defined as jaundice. Bilirubin is produced from breakdown of red blood cells. Before it is processed by the liver it is in indirect form. The rise of this form of bilirubin leads to Indirect jaundice. After processing into the liver it is converted to direct form which passes into the intestine through the bile duct. Bile duct is a tube like structure which connects the liver to small intestine. From intestine the direct bilirubin is absorbed into the blood and excreted by the kidneys. Any problem in the liver or bile duct can result into direct or cholestatic (absence of bile flow) jaundice. Read more	Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine http://www.ncbi.nlm.nih.gov/pubmed/24304457 Zhang W, Guo Z, Zhang L, Liu Z, Li J, Ji Z, Xu R, Zhao N, Li F, Chen X, Yan Y, Zhang J, An Q, Yang H, Den Z, Shao Z. Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine. J Viral Hepat. 2013 Dec; 20(12):875-81 Abstract Published on: Dec-2013 Read more
Prevention and risk factors of Hepatitis B recurrence after living donor liver transplantation http://www.ncbi.nlm.nih.gov/pubmed/24117684 Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK, Choi JY. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation. J GastroenterolHepatol. 2014 Jan;29(1):151-6. Abstract BACKGROUND AND AIM: Without effective prophylaxis, liver transplantation (LT) for hepatitis B virus (HBV)-related liver disease is frequently complicated by severe and rapidly progressive HBV recurrence. The combination of low-dose hepatitis B immunoglobulin (HBIG) and the new nucleos(t)ide analog, entecavir, as prophylaxis for HBV recurrence after living-donor LT (LDLT) were analyzed. METHODS: Published on: Jan-2014 Read more	IAP CLF Meet 2013 IAP CLF Meet 2013
Treatment of patients with dual hepatitis C virus and hepatitis Bvirus infection: Resolved and unresolved issues http://www.ncbi.nlm.nih.gov/pubmed/24199625 Liu CJ. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues. J GastroenterolHepatol. 2014 Jan;29(1):26-30. Abstract Published on: Jan-2014 Read more	Hepatomegaly, Diarrhea and failure to thrive - lesson of a life time Source Event :Case discussions in Pediatric Liver Diseases organised by Children's Liver Foundation and Indian Academy of pediatric, Mumbai on 14th and 15th December 2013. Presented by Dr Meghana Nadiger Moderated by Dr Y K Amdekar Panelists Dr Girish Gupte Dr Ujjal Poddar Dr Pravin Rathi
Perinatal transmission of Hepatitis C virus http://www.ncbi.nlm.nih.gov/pubmed/23919905 Indolfi G, Azzari C, Resti M. Perinatal transmission of hepatitis C virus. J Pediatr. 2013 Dec; 163(6):1549-1552.e1. Abstract Hepatitis C virus (HCV) is a leading cause of chronic viral hepatitis in children. Before 1992, when the universal screening of blood products began, hepatitis C was spread commonly through transfusions and organ transplants.1 At present, children acquire the infection through the use of blood-contaminated objects (syringes and other equipment) or from mothers with hepatitis C. Transmission from mother to child is the major source of acquisition of HCV infection in children. Published on: Dec-2013	Rickets and liver disease Source Event :Case discussions in Pediatric Liver Diseases organised by Children's Liver Foundation and Indian Academy of pediatric, Mumbai on 14th and 15th December 2013. Presented by Dr. Abhamoni Baro Moderated by Dr. John Matthai Panelists: Dr. S K Yachha Dr. Archana Kher Dr. Girish Gupte
Ultrasonographic predictors of esophageal varices http://www.ncbi.nlm.nih.gov/pubmed/23941999 de Alcantara RV, Yamada RM, Cardoso SR, de Fátima M, Servidoni CP, Hessel G. Ultrasonographic predictors of esophageal varices. J PediatrGastroenterolNutr. 2013 Dec; 57(6):700-3. Abstract OBJECTIVE: The aim of this study was to identify ultrasonographic predictors of esophageal varices (EVs) in children and adolescents with chronic liver disease (CLD) and extrahepatic portal venous obstruction (EHPVO). METHODS: Published on: Dec-2013 Read more	Diarrhea and Hepatosplenomegaly Source Event :Case discussions in Pediatric Liver Diseases organised by Children's Liver Foundation and Indian Academy of pediatric, Mumbai on 14th and 15th December 2013. Presented by Dr Ravindra Kumar Sharma Moderated by Dr Vishnu Biradar Panelists Dr Malathi Sathiyasekaran Dr Girish Gupte Dr Rajesh Sainani

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube